
Mark Luedde
@luddemark
Clinician Scientist. Special Interest in Heart Failure.
ID: 1404858956317704195
15-06-2021 17:51:01
810 Tweet
229 Takipçi
319 Takip Edilen


Cardiovascular disease in chronic kidney disease. A State-of-the-Art review just published in #EHJ 👉 ow.ly/yP8e50VyHVO Rocco Montone EHJ Editor-in-Chief




🗞️ The use of #LVEF in the diagnosis and management of #heartfailure. A clinical consensus statement of the #HFA of European Society of Cardiology, the HFSA & the 第28回日本心不全学会学術集会 European Society of Cardiology Journals Giuseppe Galati Amr Abdin Henry Han bit.ly/3Gk76NK



#DGKJahrestagung: Die Key Points des gerade beendeten Vortrags – kompakt und übersichtlich in der Summary Card! "SGLT2 inhibitors are associated with a reduced incidence of atrial fibrillation in patients with type 2 diabetes mellitus " Sprecher: Jamschid Sedighi Diskutant: N. Marx


Unterschätztes Problem VHF und Pulmonale Hypertonie! Wichte Übersicht von Samuel Sossalla und Team! Mark Luedde AGEP Young DGK #DGKJahrestagung #DGK #DGK2025JT #KardiovaskuläreMedizin #Kardiologie


Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities: A Scientific Statement From the American Heart Association and American College of Cardiology Circulation ahajournals.org/doi/10.1161/CI…



📢 Practical Compendium of Antiarrhythmic Drugs: A Clinical Consensus Statement of #EHRA _ESC 👉 ow.ly/HOaX50VAMU8 Europace Editor-in-Chief Giulio Conte Dominik Linz Francesco Santoro, MD, PhD Xiaodong Zhang (Andy), MD, PhD, FHRS, FACC Marco Vitolo Ⓜ️ Davide Mei #Europace #arrhythmias







SGLT2 inhibitors may be good for your heart in many ways. Here is one of them onlinelibrary.wiley.com/share/author/5… Samuel Sossalla Uniklinik Giessen DiRü Jamschid Sedighi Tom Luedde Christian Sohns

There are so many lessons out there that working in a crazy place like the ICU teaches you. Curious what other ones people have to share! Philippe Rola John Basmaji Marat Slessarev MD PhD Kiran Rikhraj IMCrit NephroPOCUS

